Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127086) titled 'A single-arm, single-center prospective clinical study on the treatment of liver fibrosis with tauroursodeoxycholic acid (TUDCA)' on June 24.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Mild to moderate liver fibrosis (F1-F3 stage)
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-30
Target Sample Size: The taurine deoxycholic acid(TUDCA) treatment group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.ht...